Menu Search
Equities

Dr Hoenle AG

HNL:BRN

Dr Hoenle AG

Actions
  • Price (CHF)52.01
  • Today's Change0.00 / 0.00%
  • Shares traded50.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 03 2021.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Dr Hoenle AG had revenues fall -8.40% from 116.09m to 106.34m, though the company grew net income from a loss of 13.36m to a smaller loss of 11.01m.
Gross margin60.59%
Net profit margin-5.40%
Operating margin-2.75%
Return on assets-3.07%
Return on equity-5.57%
Return on investment-3.74%
More ▼

Cash flow in EURView more

In 2023, Dr Hoenle AG increased its cash reserves by 30.65%, or 2.19m. The company earned 3.14m from its operations for a Cash Flow Margin of 2.96%. In addition the company generated 2.65m cash from investing, though they paid out 3.42m more in financing than they received.
Cash flow per share0.6812
Price/Cash flow per share17.11
Book value per share15.43
Tangible book value per share12.17
More ▼

Balance sheet in EURView more

Dr Hoenle AG has a Debt to Total Capital ratio of 37.13%, a lower figure than the previous year's 42.36%.
Current ratio1.98
Quick ratio0.8544
Total debt/total equity0.591
Total debt/total capital0.3713
More ▼

Growth rates in EUR

SmartText is unavailable
Div yield(5 year avg)0.60%
Div growth rate (5 year)--
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		48.68
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.